Business

Applications for the G4A Global Accelerator Are Now Open

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe.

Philips Expands its Sleep & Respiratory Care Portfolio with the Acquisition of NightBalance

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has developed an innovative, easy to use device to treat positional obstructive sleep apnea and positional snoring. Financial details of the transaction were not disclosed.

Siemens Healthineers Fully on Track to Meet the Targets

Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR 3.2 billion on a comparable basis. Despite continuing negative currency effects, the profit margin adjusted for non-recurring effects increased by 90 basis points to 17.4 percent, while adjusted profit was stable at EUR 560 million compared to the second quarter of 2017.

Novartis Launches FocalView App, Providing Opportunity for Patients to Participate in Ophthalmology Clinical Trials from Home

Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients. By adapting the design of clinical trials to suit the daily routine of patients, the app may reduce barriers to participation, leading to a more nuanced understanding of ophthalmic diseases and potentially accelerating the development of novel treatments.

Philips Partners with the Medical University of Vienna to Provide Asthma and Allergy Sufferers with a Pollen Forecast

This World Allergy Week (April 22 - 28) and World Asthma Day (May 1), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is helping parents take charge of their children's asthma and allergy symptoms through awareness initiatives in more than 20 countries worldwide.

FDA Permits Marketing of Artificial Intelligence-Based Device to Detect Certain Diabetes-Related Eye Problems

The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back of the eye.

Pitch for Smarter Healthcare at the Roche Innovation Summit

The European Innovation Council (EIC) SME Instrument and Roche invite you to pitch your ideas and breakthroughs on healthcare tech at the Roche Innovation Summit on the 19th and 20th of June in Basel, Switzerland. On a yearly basis, Roche organises an internal Innovation summit, to inspire, connect, develop and advance their organisation.

Business and Industry News

Applications for the G4A Global Accelerator Are Now Open

Philips Expands its Sleep & Respiratory Care Portfolio with the Acquisition of NightBalance

Siemens Healthineers Fully on Track to Meet the Targets

Novartis Launches FocalView App, Providing Opportunity for Patients to Participate in Ophthalmology Clinical Trials from Home

Philips Partners with the Medical University of Vienna to Provide Asthma and Allergy Sufferers with a Pollen Forecast

FDA Permits Marketing of Artificial Intelligence-Based Device to Detect Certain Diabetes-Related Eye Problems

Pitch for Smarter Healthcare at the Roche Innovation Summit

More eHealth News ...

Latest Business News

Latest Research News

Latest Conferences News

Latest Jobs